Top Suppliers:I want be here



1173154-32-9

1173154-32-9 structure
1173154-32-9 structure
  • Name: ALB-127158(a)
  • Chemical Name: ALB-127158
  • CAS Number: 1173154-32-9
  • Molecular Formula: C23H21FN4O2
  • Molecular Weight: 404.44
  • Catalog: Signaling Pathways GPCR/G Protein MCHR1 (GPR24)
  • Create Date: 2018-06-19 06:51:10
  • Modify Date: 2024-01-11 18:57:16
  • ALB-127158(a) is a potent and selective melanin concentrating hormone 1 (MCH1) receptor antagonist.

Name ALB-127158
Synonyms ALB-127158(a)
Description ALB-127158(a) is a potent and selective melanin concentrating hormone 1 (MCH1) receptor antagonist.
Related Catalog
Target

MCH1 receptor[1]

In Vitro ALB-127158(a) has high affinity for the MCH1 receptor (7 nM) with good selectivity over a range of other G-protein coupled receptors (GPCRs), ion channels and transporters, including the MCH2 receptor. In vitro functional assays confirmed that ALB-127158(a) is a potent and selective MCH1 receptor antagonist[1].
In Vivo In a mouse diet induced obesity (DIO) model, ALB-127158(a) produces a significant sustained decrease in body weight and food intake in the range of 5-15 mg/kg bid. The weight reduction is predominantly due to a decrease in fat content. In high fat diet (HFD) rats, ALB-127158(a) produces significant weight loss and food reduction at doses as low as 1.25 mg/kg po. Doses > 1.25 mg/kg po produces weight loss > 6%, maximal weight loss of about 10% in rats is observed at 10 mg/kg. Following single and multiple oral administration of ALB-127158(a), ALB-127158(a) is rapidly absorbed (median tmax attains between 1 and 3 h post dose in lean and overweight/obese subjects) with a trend to decrease over dose suggesting a slower absorption rate of ALB-127158(a) at lower doses. After single doses, ALB-127158(a) has a mean half-life (t1/2) of 18 to 21 h. Slightly longer mean t1/2 estimates of approximately 26 h are obtained following multiple dosing in overweight/obese subjects; steady-state plasma ALB-127158(a) is attained within 6 to 8 days of dosing[1].
References

[1]. Moore NA, et al. From preclinical to clinical development: the example of a novel treatment for obesity. Neurobiol Dis. 2014 Jan;61:47-54.

Molecular Formula C23H21FN4O2
Molecular Weight 404.44
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.